Congenital Hydrocephalus: Understanding Neural Tube Defects
Neural tube defects (NTDs) are a major cause of congenital hydrocephalus. The neural tube forms the brain and spinal cord during early fetal development (weeks 3-4). When it fails to close properly, NTDs result.
Key Neural Tube Defects Linked to Hydrocephalus
Spina Bifida (Myelomeningocele)
The most common NTD. The spinal column doesn't close completely, exposing the spinal cord. Over 80% of infants with myelomeningocele develop hydrocephalus due to:
- Chiari II malformation (cerebellar tonsils herniate downward, obstructing CSF flow)
- Impaired CSF absorption from associated abnormalities
Anencephaly
Severe NTD where the brain and skull don't develop properly. Usually fatal shortly after birth; hydrocephalus may be present but is not the primary concern.
Encephalocele
Brain tissue protrudes through a skull defect. Can obstruct CSF pathways, causing hydrocephalus.
Mechanism of Hydrocephalus in NTDs
NTDs disrupt normal CSF circulation through structural malformations (Chiari II), scarring from surgical repair, or impaired arachnoid granulation function. The resulting CSF buildup increases intracranial pressure, potentially damaging developing brain tissue.
Prevention and Detection
- Folic acid supplementation before and during early pregnancy reduces NTD risk by up to 70%
- Prenatal ultrasound can detect NTDs and associated hydrocephalus
- Maternal serum alpha-fetoprotein (MSAFP) screening
Treatment
Typically involves surgical CSF diversion (ventriculoperitoneal shunt or endoscopic third ventriculostomy) after birth, often coordinated with spina bifida repair.
Genetic Disorders - Related Articles
- Marfan Syndrome Life Expectancy: Modern Outcomes with Proper Management
- Empty Nest Syndrome: Emotional Impact, Coping Strategies, and Growth Opportunities
- Etymology of “Syndrome”: From Greek “Running Together” to Modern Medicine
- Understanding Endophthalmitis: Eye Infection After Cataract Surgery
- Understanding Gender Identity: Current Science on Transgender Etiology
- Pharmacogenetics: Advancing Personalized Drug Development
- Beneficial Mutations: The Sickle Cell Trait Explained
